BiotechTube
Home/Rhelixa/仲木 竜 (Ryū Nakaki)
仲竜

仲木 竜 (Ryū Nakaki)

CEO

Rhelixa

Therapeutic Areas

AgingNeurologyMental HealthInfectious Disease

Rhelixa Pipeline

DrugIndicationPhase
Epilock® Biological Age TestBiological Aging AssessmentCommercial
DNA Methylation Model for MCIMild Cognitive Impairment DetectionResearch/Development
COVID-19 Severity PredictionCOVID-19 PrognosisResearch/Development
Stress/Depression BiomarkerYouth Mental Health AssessmentResearch/Development

Leadership Team at Rhelixa

NS
Not specified on website
CSO
View full Rhelixa profile